Author

O. Herrera-Restrepo

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Parents’ and caregivers’ views on pediatric meningococcal disease and serogroup B vaccination

ABSTRACT In the United States (US), the highest incidence of invasive meningococcal disease (IMD) is among infants aged ≤ 1 year (y). While most IMD cases in US infants are caused by meningococcal serogroup B (MenB), there is no MenB vaccine approved or recommended for US children < 10 y. This study sought to understan...

O. Herrera-Restrepo, Vasudha Gupta, Sophie Jacobovitz et al. · Human Vaccines & Immunothera... · 0 citations

Open access Sep 2026

Health Outcomes, Healthcare Resource Use, and Economic Burden of Invasive Meningococcal Disease in the United States Among Children Aged <11 Years.

BACKGROUND/OBJECTIVE Although uncommon, invasive meningococcal disease (IMD) is a serious and life-threatening illness. In the United States (US), incidence is highest among infants aged <1 year, but research characterizing pediatric IMD burden is limited. This study aimed to evaluate health outcomes and economic burde...

O. Herrera-Restrepo, Elizabeth Packnett, Megan K. Richards et al. · PharmacoEconomics - Open · 0 citations

Review Open access Jul 2026

Healthcare professionals' perspectives and preferences regarding adolescent meningococcal disease vaccination in the United States.

BACKGROUND Invasive meningococcal disease (IMD) is a vaccine-preventable, serious disease. In 2023-2024, the United States (US) Advisory Committee on Immunization Practices (ACIP) proposed revisions to the adolescent meningococcal vaccine schedule. This survey aimed to understand healthcare professionals' (HCPs') persp...

O. Herrera-Restrepo, Laurie Batchelder, T. Pinto et al. · Expert Review of Vaccines · 0 citations